COMPANY HISTORY / RETAINED ORIGINAL SOURCES

What did the company say,
and what came next?

In the reviewed release recorded 26 Sep 2026, 07:20 UTC, ORION retains 2 historical announcement records as of 26 Sep 2026 for Altimmune (ALT). Read the original sources and their publication dates below or inspect the dated catalog.

Last updated: 26 Sep 2026, 07:20 UTC · reviewed catalog release, not a fresh source check

1 Choose one ticker
2 Read the evidence
3 Keep a starting point

10 companies · 24 retained records · Reviewed 2026-09-26T07:20:44Z.

What did ALT disclose about Pemvidutide?

Altimmune · MOMENTUM Phase 2 48-week results · 2 retained source records as of 26 Sep 2026.

Earlier selected statement

Read the source context →

Stated timing: Q4 2023

Source published 11 May 2023 · Original announcement. ORION first recorded 26 Sep 2026, 07:20 UTC.

Later selected disclosure

Read the source context →

Source published 30 Nov 2023 · Original announcement. ORION first recorded 26 Sep 2026, 07:20 UTC.

Follow-up research question

What do the complete 48-week results show about weight change, discontinuations and safety?

YOUR PRIVATE STARTING POINT

Compare with what you saved.

Save a milestone to your account’s Notebook. Reopen its original snapshot here and compare with this reviewed catalog. Email subscriptions use a separate opt-in.

Manage Notebook allowance

Source index · readable without the interactive view

Altimmune (ALT)

MOMENTUM Phase 2 48-week results

Q1 2023 update: MOMENTUM timing
Altimmune expected the 48-week topline results of the MOMENTUM Phase 2 obesity trial in the fourth quarter of 2023.
Stated timing: Q4 2023
Original announcement.
Source published (published_at)
11 May 2023
Event effective (effective_at)
UNAVAILABLE
ORION first seen (first_seen_at)
26 Sep 2026, 07:20 UTC
ORION ingested (ingested_at)
26 Sep 2026, 07:20 UTC
MOMENTUM 48-week topline announcement
Altimmune announced the 48-week MOMENTUM topline results on November 30, 2023. This records publication of the readout, not an ORION efficacy comparison or investment recommendation.
Original announcement.
Source published (published_at)
30 Nov 2023
Event effective (effective_at)
30 Nov 2023
ORION first seen (first_seen_at)
26 Sep 2026, 07:20 UTC
ORION ingested (ingested_at)
26 Sep 2026, 07:20 UTC

Scope

These selected company announcements preserve publication dates separately from ORION’s later recording times. Registry completion dates and follow-up research questions are separate from company announcements; this historical release does not establish current guidance or continuous monitoring.

Coverage & method → · Corrections · Catalog manifest